Understanding the complex interactions between GFPT2, NKX3-2, Caspases, and Bcl-2 family proteins may offer valuable insights into developing strategies to combat paclitaxel resistance in EOC, guiding the creation of novel therapeutic approaches for this challenging cancer. Here, BCL2 is linked to cancer.